PNV 3.98% $2.09 polynovo limited

To play the devil's advocate, I see Dr Amaral's only corporate...

  1. 274 Posts.
    lightbulb Created with Sketch. 165
    To play the devil's advocate, I see Dr Amaral's only corporate role seems to have been with the Ethicon division of J&J from 2009 to 2019. This fairly neatly corresponds with the period when Ethicon was the supplier of the vaginal mesh implant that caused so much trouble and injury and got J&J sued. Justice Fullerton, in ruling against Ethicon in the Australian proceedings, found that Ethicon had concealed what it knew about the adverse effects of the product. That history of being associated with that deceptively promoted product, which is no doubt still present in minds of many clinicians, doesn't sound like an unqualified advantage to me, especially as PNV is expected eventually to get into tissue-supports meshes itself, like hernia and breastfeeding sling products.
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.09
Change
0.080(3.98%)
Mkt cap ! $1.442B
Open High Low Value Volume
$2.03 $2.09 $2.03 $1.476M 710.6K

Buyers (Bids)

No. Vol. Price($)
3 5010 $2.08
 

Sellers (Offers)

Price($) Vol. No.
$2.09 135016 10
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
$2.09
  Change
0.080 ( 3.33 %)
Open High Low Volume
$2.03 $2.09 $2.03 302647
Last updated 15.59pm 03/05/2024 ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.